I appreciate that.
I want to switch gears a bit, because the other piece—it's a smaller piece—relates to the $1.2-billion writedown of expired COVID treatments and vaccines and another $3.5 billion for loans and receivables related to emergency supports. This has been a politically contentious issue as well, and there have been accusations that the CEBA program was mismanaged. Obviously, the Auditor General has a report on this, and there have been some questions as to the value of the CEBA program and what purpose it served for small businesses.
Mr. Forbes, could you take us back to March 2020 and the dire straits in the ensuing months that small businesses were facing? How necessary was the CEBA program for businesses to survive?